Rti surgical, inc (rti) and tutogen medical gmbh (tmi), a wholly owned subsidiary of rti, received a complaint as part of the fortiva appear trial.The reported complaint indicated that a patient with history of stage 0 breast cancer underwent a nipple removing, skin sparing mastectomy with breast reconstruction.Two fortiva porcine dermis grafts were implanted on (b)(6) 2020 (serial ids (b)(4) on the left side and (b)(4) on the right side).This report pertains to serial id (b)(4).On (b)(6) 2020 the patient developed pain and seroma formation.The information provided indicated that a 200ml and an 80ml seroma were drained.It is unknown at this time if the patient developed the seromas in one breast or bilaterally.The seromas resolved after drainage.
|